News
Do you want to know more about Janus Life Sciences? Read our news.
Do you want to know more about Janus Life Sciences? Read our news.
In the highly regulated environment of EU clinical trials, safeguarding personal data and commercially confidential information (CCI) is critical – not only for legal compliance, but also for maintaining trust among stakeholders. For companies leveraging translation and localization services to support global clinical research, understanding how these services intersect with data protection regulations such as the GDPR and EMA policies is essential. Janus Worldwide plays a pivotal role in ensuring the confidentiality and security of sensitive information through industry-leading localization solutions.
Medical translation services play a critical role in ensuring accurate communication in the healthcare industry. The precision, clarity, and reliability of translated medical documents directly impact patient safety, clinical outcomes, and regulatory compliance. Errors in medical terminology translation can lead to severe, even life-threatening consequences. That’s why selecting a trusted and experienced medical translation company is not just important—it is essential.
It is now becoming clear that artificial intelligence (AI) is inescapable: it is used everywhere, including as part of translation workflow automation. Many translation companies are concerned that they will be forced out of the market, while a lot of freelance translators and client-side translation departments are wondering what their futures might look like.
Selecting the right linguists to translate life science content is a critical process due to the specialized nature of the field and the fact that the market is highly regulated. Documents may comprise a mixture of complex scientific data, medical terminology, and technical language. Inaccurate translations in clinical trial documentation, patient information leaflets, or drug labels can jeopardize patient safety, leading to the improper use of medication or devices. It is vital to ensure accuracy, compliance, cultural sensitivity, and clear communication, all of which are essential for the safety, effectiveness, and success of life science products and services.
Pharmaceutical companies face numerous translation challenges, especially when it comes to translating medical and scientific documents. They must comply with the various regulatory requirements across different countries for clinical trials, marketing authorization applications, and product labeling.
The implementation of the new MDR has introduced several new changes and requirements regarding the labeling and usage instructions for medical devices. These modifications impact the content that requires translation. Specifically, the MDR underscores the importance of providing clear and understandable information to users, encompassing patients, healthcare professionals, and even software UI now recognized as part of product labeling. The classification of software has undergone drastic changes under the EU MDR and IVDR, resulting in virtually no medical device software falling under low-risk categories (unlike the situation under the MDD). The updated language requirements for software are expected to influence manufacturers’ software translation/localization policies, prompting a more rigorous examination of the translated UI.
Germany
51063 Köln,
Schanzenstr. 36 / Geb. 31
Phone:
+49 176 2391 4888
+49 2 212 718 30 83
Extension number: 802
Email:
info@janusww.com
2004 — 2026 Janus Life Sciences. Medical translation services. All rights reserved.
